103-106DOI: 10.17235/reed.2021.8003/2021
Vicent Hernández, María Luisa de Castro, María Salinas-Rojo, Alberto Fernández, David Martínez-Ares, Luciano Sanromán, Juan Ramón Pineda, Amalia Carmona, Carlos Salgado-Álvarez, Jesús Martínez-Cadilla, Santos Pereira, José Ignacio García-Burriel, Carlos González-Portela, Santiago Vázquez, José Ignacio Rodríguez-Prada, VICENT HERNANDEZ RAMIREZ on behalf of Epi-IBD*,
* Epi-IBD: VICENT HERNANDEZ RAMIREZ
Abstract
Objective: to validate the incidence of inflammatory bowel disease (IBD) reported in Vigo in 2010 within the Epi-IBD study, which was the highest incidence reported so far in Spain.
Methods: an epidemiological, prospective, population-based inception cohort study. All incident cases of IBD living in the Vigo area at diagnosis from January 1 to December 31, 2011 were included.
Results: one hundred patients were diagnosed (62 % men; median age, 43.27 years): 49 with ulcerative colitis (UC), 34 with Crohn’s disease (CD), and 17 with IBD unclassified (IBDU). The incidence (per 100,000 inhabitants/year) was 17.56 (CD: 5.97; UC: 8.60; IBDU: 2.98), similar to that reported in 2010. The incidence in the non-pediatric population was 19.66 (CD: 6.89, UC: 9.52; IBDU: 3.04). CD and UC phenotype was similar in 2010 and 2011.
Conclusion: this study supports the increased incidence of EII in the Vigo area reported in 2010.
New comment
Comments
No comments for this article
References
1. Burisch J, Pedersen N, Čuković-Čavka S, et al. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut 2014;63(4):588-97.
2. Vegh Z, Burisch J, Pedersen N, et al. Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort. J Crohns Colitis 2014;8(11):1506-15.
3. Fernández A, Hernández V, Martínez-Ares D, et al. Incidence and phenotype at diagnosis of inflammatory bowel disease. Results in Spain of the EpiCom study. Gastroenterol Hepatol 2015;38(9):534-40.
4. Munkholm P. Crohn’s disease--occurrence, course and prognosis. An epidemiologic cohort-study. Dan Med Bull 1997;44(3):287-302.
5. Langholz E. Ulcerative colitis. An epidemiological study based on a regional inception cohort, with special reference to disease course and prognosis. Dan Med Bull 1999;46(5):400-15.
6. Instituto Nacional de Estadística. Censo de Población 2011 [Internet]. Disponible en: https://www.ine.es/jaxi/Tabla.htm?path=/t20/e244/avance/p02/l0/&file=1mun36.px&L=0
7. Burisch J, Cukovic-Cavka S, Kaimakliotis I, et al. Construction and validation of a web-based epidemiological database for inflammatory bowel diseases in Europe An EpiCom study. J Crohns Colitis 2011;5(4):342-9.
8. Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet (London, England) 2018;390(10114):2769-78.
9. Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2021;18(1):56-66.
10. Ruiz Ochoa V. Epidemiologic study of Crohn’s disease in Galicia from 1976 to 1983. Rev Esp Enferm Apar Dig 1984;66(4):273-9.
11. Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996;39(5):690-7.
12. Chaparro M, Barreiro-de Acosta M, Benítez JM, et al. EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain. Therap Adv Gastroenterol 2019;12:1756284819847034.
13. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142(1):46-54.e42; quiz e30.